JG
KLRS

Jefferies Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Jefferies Group’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-713
Closed -$630K – 1360
2020
Q4 		$630K Buy
+713
New +$630K 0.01% 612